AXSM earnings
Axsome Therapeutics (AXSM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
AXSM earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | -0.99 | -0.89 | -10.98% | $218.38M |
| Q1 2026 | May 4, 2026 | -1.26 | -0.85 | -48.24% | $191.20M |
| Q4 2025 | Feb 23, 2026 | -0.71 | -0.70 | -1.43% | $196.00M |
| Q3 2025 | Nov 3, 2025 | -0.94 | -0.82 | -14.63% | $170.99M |
| Q2 2025 | Aug 4, 2025 | -0.92 | -1.00 | 8.00% | $150.04M |
| Q1 2025 | May 5, 2025 | -1.22 | -1.26 | 3.17% | $121.46M |
| Q4 2024 | Feb 18, 2025 | -1.54 | -1.00 | -54.00% | $118.77M |
| Q3 2024 | Nov 12, 2024 | -1.34 | -1.38 | 2.90% | $104.76M |
| Q2 2024 | Aug 4, 2024 | -1.67 | -1.30 | -28.46% | $87.17M |
| Q1 2024 | May 6, 2024 | -1.09 | -1.20 | 9.17% | $75.00M |
| Q4 2023 | Feb 20, 2024 | -2.08 | -1.21 | -71.90% | $71.53M |
| Nov 6, 2023 | -1.32 | -1.24 | -6.45% | – | |
| Aug 6, 2023 | -1.54 | -1.24 | -24.19% | – | |
| May 8, 2023 | -0.22 | -1.13 | 80.53% | – | |
| Feb 27, 2023 | -1.28 | -1.18 | -8.47% | – | |
| Nov 7, 2022 | -1.03 | -1.10 | 6.36% | – | |
| Aug 9, 2022 | -1.06 | -1.19 | 10.92% | – | |
| May 2, 2022 | -1.03 | -1.02 | -0.98% | – | |
| Mar 1, 2022 | -0.90 | -0.99 | 9.09% | – | |
| Nov 8, 2021 | -0.93 | -0.94 | 1.06% | – |
- AXSM reports next on Nov 2, 2026, with EPS of -0.53 expected.
- AXSM beat EPS estimates in 24 of its last 43 reports.
Updated 2026-11-02 17:14 UTC